パチスロ 規制 最新(gatifloxacin) Tablets, a broad-spectrum antibacterial agent, in Japan
September 30, 2008
Kyorin Pharmaceutical パチスロ 規制 最新., Ltd. (Tokyo, President: Itaru Kojo), a wholly owned subsidiary of Kyorin パチスロ 規制 最新., Ltd., and Dainippon Sumitomo Pharma パチスロ 規制 最新., Ltd. (Osaka, President: Masayo Tada) announce that they have decided to voluntarily discontinue commercialization of Gatiflo® (gatifloxacin) Tablets, a broad-spectrum antibacterial agent, in Japan as of September 30, 2008.
Please see the PDF file below for details.
